Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,742 | 2 | 83.7% |
| Food and Beverage | $1,117 | 43 | 16.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Flowonix Medical Incorporated | $5,742 | 2 | $0 (2020) |
| Piramal Critical Care | $279.66 | 4 | $0 (2018) |
| Allergan, Inc. | $244.44 | 15 | $0 (2022) |
| AbbVie Inc. | $183.53 | 8 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $160.88 | 5 | $0 (2018) |
| Medtronic, Inc. | $91.89 | 4 | $0 (2024) |
| Saol Therapeutics Inc. | $67.75 | 4 | $0 (2019) |
| Merz Pharmaceuticals, LLC | $56.26 | 2 | $0 (2024) |
| TerSera Therapeutics LLC | $32.48 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $167.96 | 6 | Medtronic, Inc. ($79.22) |
| 2023 | $183.53 | 8 | AbbVie Inc. ($183.53) |
| 2022 | $12.17 | 1 | Allergan, Inc. ($12.17) |
| 2021 | $54.04 | 3 | Allergan, Inc. ($41.37) |
| 2020 | $3,554 | 5 | Flowonix Medical Incorporated ($3,500) |
| 2019 | $47.00 | 3 | Allergan Inc. ($26.18) |
| 2018 | $459.65 | 11 | Piramal Critical Care ($279.66) |
| 2017 | $2,380 | 8 | Flowonix Medical Incorporated ($2,242) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/08/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2018 | Piramal Critical Care | GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Pharmacology | ||||||
| 10/10/2018 | Piramal Critical Care | GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Pharmacology | ||||||
| 09/19/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/10/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/11/2018 | Piramal Critical Care | GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Pharmacology | ||||||
| 04/24/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 03/28/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/26/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/08/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $73.74 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/06/2018 | Piramal Critical Care | GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) | Food and Beverage | In-kind items and services | $119.27 | General |
| Category: Pharmacology | ||||||
| 01/17/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 11/16/2017 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/03/2017 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/13/2017 | Flowonix Medical Incorporated | Prometra II (Device) | Consulting Fee | Cash or cash equivalent | $2,241.66 | General |
| Category: Pain Management Pump | ||||||
| 10/03/2017 | Allergan Inc. | BOTOX - NEURO REHAB (Drug) | Food and Beverage | In-kind items and services | $38.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2017 | Saol Therapeutics Inc. | Dysport (Drug), Lioresal Intrathecal | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Spasticity | ||||||
| 08/28/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 08/09/2017 | Saol Therapeutics Inc. | Dysport (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Spasticity | ||||||
| 02/01/2017 | Saol Therapeutics Inc. | Lioresal Intrathecal (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Severe Spasticity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 115 | 369 | $72,773 | $22,591 |
| 2022 | 3 | 77 | 461 | $89,081 | $25,275 |
| 2021 | 5 | 110 | 406 | $84,864 | $24,440 |
| 2020 | 4 | 142 | 400 | $81,051 | $24,352 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 295 | $56,935 | $17,952 | 31.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 30 | $11,130 | $2,950 | 26.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 28 | 44 | $4,708 | $1,689 | 35.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 48 | 416 | $79,644 | $22,637 | 28.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 18 | $6,608 | $1,829 | 27.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 27 | $2,829 | $808.22 | 28.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 43 | 297 | $55,242 | $16,154 | 29.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 42 | $11,214 | $3,190 | 28.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 29 | $10,353 | $3,076 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 12 | 21 | $6,321 | $1,510 | 23.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 14 | 17 | $1,734 | $509.32 | 29.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 62 | 310 | $57,660 | $17,909 | 31.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 37 | 37 | $13,209 | $4,078 | 30.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 17 | 24 | $7,224 | $1,452 | 20.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 26 | 29 | $2,958 | $913.15 | 30.9% |
About Dr. Stuart Yablon, M.D
Dr. Stuart Yablon, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265477459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Yablon, M.D has received a total of $6,859 in payments from pharmaceutical and medical device companies, with $167.96 received in 2024. These payments were reported across 45 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($5,742).
As a Medicare-enrolled provider, Yablon has provided services to 444 Medicare beneficiaries, totaling 1,636 services with total Medicare billing of $96,657. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Physical Medicine & Rehabilitation, Physical Medicine & Rehabilitation
- Location Grand Rapids, MI
- Active Since 06/19/2006
- Last Updated 03/31/2021
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1265477459
Products in Payments
- Prometra II (Device) $5,742
- BOTOX (Biological) $302.58
- GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) $279.66
- NUEDEXTA (Drug) $160.88
- SYNCHROMEDII (Device) $79.22
- BOTOX THERAPEUTIC (Biological) $71.86
- Xeomin (Biological) $56.26
- BOTOX - NEURO REHAB (Drug) $38.97
- Prialt (Drug) $32.48
- Dysport (Drug) $32.37
- Lioresal (baclofen) (Drug) $20.82
- BOTOX (Drug) $14.56
- Lioresal Intrathecal (Drug) $14.56
- SYNCHROMED (Device) $12.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Grand Rapids
Emily Gladstone, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $10,120
Dr. Sampson Ho, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $4,434
Adam Hull, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $4,352
Dr. Jonathan Vandenberg, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $3,860
Dr. Aashish Deshpande, Md, MD
Physical Medicine & Rehabilitation — Payments: $3,499
Dr. Adam Rush, Md, MD
Physical Medicine & Rehabilitation — Payments: $3,241